Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

These drugs are often able to alter the course of some forms of inflammatory arthritis -- diseases such as rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis -- that can destroy ...

Dr. Ruderman’s clinical focus is on Rheumatoid Arthritis, Psoriatic Arthritis (combined program with Dermatology), Spondyloarthritis. Dr. Gordon has received honoraria or research support from ...

Psoriatic arthritis is a complex disease that causes widespread symptoms. Besides the changes to your joints and skin, PsA ...

Arthritis Rheum 59: 686–691 Enthesitis is thought to underlie most manifestations of psoriatic arthritis. While there are several tools that assess enthesitis in ankylosing spondylitis ...

effective in psoriatic arthritis and rheumatoid arthritris, in a double-blind, randomized, placebo-controlled trial of 45 patients with ankylosing spondylitis. The proportion of patients who ...